OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NTV56

Nonthavej Hospital PCL

Healthcare Facilities & ServicesVerified

Nonthavej Hospital PCL maintains a strong liquidity position with a current ratio of 5.78, indicating a robust ability to meet short-term obligations. The company has no long-term debt and a debt-to-equity ratio of 0.0, suggesting a conservative capital structure with minimal leverage. Profitability metrics show a return on equity of 9.82% and a return on assets of 8.72%, both exceeding the typical thresholds for healthcare facilities. These figures indicate efficient use of equity and assets to generate profit, aligning with industry expectations for asset-heavy operations. The company's revenue is concentrated in Thailand, with no disclosed international operations. Its services span a broad range of medical specialties, including gynecology, orthopedic surgery, and cosmetic procedures, which contribute to diversified revenue streams. The hospital operates 208 beds and offers various ward types, supporting both standard and premium patient care. Growth trajectory is supported by a positive operating cash flow of 436.14 million THB and a free cash flow of 22.81 million THB. The company's capital expenditure of -233.65 million THB indicates a net reduction in capital spending, which may reflect asset optimization or maintenance rather than expansion. Risk assessment reveals low liquidity and dilution risks, with no immediate filing-based flags detected. The absence of long-term debt and a high current ratio further support the low liquidity risk profile. The company's shares outstanding remain unchanged between basic and diluted, indicating no near-term dilution pressure. Recent financial filings and transcripts do not highlight any material events or strategic shifts. The company's operations remain stable, with no disclosed regulatory or legal challenges that could impact its financial performance.

30-day price · NTV-2.90 (-13.2%)
Low$19.00High$23.00Close$19.00As of15 May, 00:00 UTC
Profile
CompanyNonthavej Hospital PCL
TickerNTV.BK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Nonthavej Hospital PCL provides comprehensive medical services including inpatient, outpatient, and emergency care, with specialized centers for minimally invasive surgery, breast cancer, and gastrointestinal health.

Classification. The company is classified under the Healthcare Facilities & Services industry within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Nonthavej Hospital PCL maintains a strong liquidity position with a current ratio of 5.78, indicating a robust ability to meet short-term obligations. The company has no long-term debt and a debt-to-equity ratio of 0.0, suggesting a conservative capital structure with minimal leverage. Profitability metrics show a return on equity of 9.82% and a return on assets of 8.72%, both exceeding the typical thresholds for healthcare facilities. These figures indicate efficient use of equity and assets to generate profit, aligning with industry expectations for asset-heavy operations. The company's revenue is concentrated in Thailand, with no disclosed international operations. Its services span a broad range of medical specialties, including gynecology, orthopedic surgery, and cosmetic procedures, which contribute to diversified revenue streams. The hospital operates 208 beds and offers various ward types, supporting both standard and premium patient care. Growth trajectory is supported by a positive operating cash flow of 436.14 million THB and a free cash flow of 22.81 million THB. The company's capital expenditure of -233.65 million THB indicates a net reduction in capital spending, which may reflect asset optimization or maintenance rather than expansion. Risk assessment reveals low liquidity and dilution risks, with no immediate filing-based flags detected. The absence of long-term debt and a high current ratio further support the low liquidity risk profile. The company's shares outstanding remain unchanged between basic and diluted, indicating no near-term dilution pressure. Recent financial filings and transcripts do not highlight any material events or strategic shifts. The company's operations remain stable, with no disclosed regulatory or legal challenges that could impact its financial performance.
Key takeaways
  • Nonthavej Hospital PCL has a strong liquidity position with a current ratio of 5.78 and no long-term debt.
  • The company's profitability metrics, including a 9.82% return on equity, indicate efficient asset and equity utilization.
  • Revenue is concentrated in Thailand, with a diverse range of medical services contributing to stable cash flows.
  • Low liquidity and dilution risks, supported by a conservative capital structure, suggest a stable financial outlook.
  • No immediate regulatory or legal challenges have been disclosed, maintaining a favorable risk profile.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTHB
Revenue$2.37B
Gross profit$637.4M
Operating income$321.6M
Net income$276.8M
R&D
SG&A
D&A
SBC
Operating cash flow$436.1M
CapEx-$233.7M
Free cash flow$22.8M
Total assets$3.17B
Total liabilities$356.1M
Total equity$2.82B
Cash & equivalents
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.82B
Net cash
Current ratio5.8
Debt/Equity0.0
ROA8.7%
ROE9.8%
Cash conversion1.6%
CapEx/Revenue-9.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricNTVActivity
Op margin13.6%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin11.7%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin26.9%19.7% medp25 19.7% · p75 39.8%above median
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-9.8%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity0.0%71.3% medp25 19.0% · p75 91.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 11:33 UTC#d7cff9dd
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 11:36 UTCJob: 31f732c5